







InnoLet
By








We ask our readers to send us those eye-straining, baffling prescriptions that they receive for inclusion in this monthly feature. If you would like to contribute to this column, send a clean photocopy of the script along with a note that describes the experience and provides the correct drug information to: Can You Read These Rxs?, Pharmacy Times, 241 Forsgate Drive, Jamesburg, NJ 08831, or fax it to 732-656-9267.















Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
3
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
4
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
5





